Savic Lidija, Mrdovic Igor, Asanin Milika, Stankovic Sanja, Krljanac Gordana, Lasica Ratko
Clinic of Cardiology and Coronary Care Unit, Clinical Centre of Serbia, Emergency Hospital; Belgrade-Serbia.
Anatol J Cardiol. 2018 Jul;20(1):21-28. doi: 10.14744/AnatolJCardiol.2018.47701.
The aim of this study was to investigate and compare the prognostic impact of renal dysfunction (RD) at admission in patients with preserved, moderately impaired and severely impaired left ventricular systolic function following ST-elevation myocardial infarction (STEMI).
We included 2436 patients with STEMI treated with primary percutaneous coronary intervention (pPCI). Patients presenting with cardiogenic shock and those on hemodyalisis were excluded. According to the left ventricular ejection fraction (EF), patients were divided in three groups: preserved left ventricular systolic function - EF >50%, moderately impaired - EF=40%-50% and severely impaired left ventricular systolic function-EF <40%. RD was defined as estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m2 at admission. The follow-up period was 6 years.
Preserved, moderately impaired and severely impaired systolic function were found in 741 (30.5%), 1367 (56.1%) and 328 (13.4%) patients, respectively. RD was present in 105 (14.2%) patients with preserved systolic function, 247 (18.1%) patients with moderately impaired, and 120 (36.5%) patients with severely impaired systolic function.Regardless of the presence of RD, 6-year mortality rates in patients with preserved, moderately impaired, and severely impaired systolic function were 2.7%, 5.2% and 31.1% respectively. Within each LVEF group, patients with RD had a worse outcome, both in the short- and long-term. In the Mulivariate Cox Analysis, RD remained an independent predictor of 6-year mortality in patients with moderately (HR 2.52, 95% CI 1.54-3.78) and severely impaired systolic function (HR 2.84, 95% CI 1.68-5.34), but not in patients with preserved left ventricular systolic function (HR 0.59, 95% CI 0.14-1.41).
Although patients with RD had higher 6-year mortallity following STEMI regardless of LVEF, RD at admission remained a strong independent predictor for 6-year mortality only in patients with moderately and severely impaired left ventricular systolic function.
本研究旨在调查并比较ST段抬高型心肌梗死(STEMI)后左心室收缩功能正常、中度受损和严重受损患者入院时肾功能不全(RD)对预后的影响。
我们纳入了2436例行直接经皮冠状动脉介入治疗(pPCI)的STEMI患者。排除出现心源性休克的患者和接受血液透析的患者。根据左心室射血分数(EF),将患者分为三组:左心室收缩功能正常-EF>50%,中度受损-EF=40%-50%,左心室收缩功能严重受损-EF<40%。RD定义为入院时估算肾小球滤过率(eGFR)<60 mL/min/1.73m²。随访期为6年。
分别在741例(30.5%)、1367例(56.1%)和328例(13.4%)患者中发现收缩功能正常、中度受损和严重受损。收缩功能正常的患者中有105例(14.2%)存在RD,中度受损的患者中有247例(18.1%)存在RD,收缩功能严重受损的患者中有120例(36.5%)存在RD。无论是否存在RD,收缩功能正常、中度受损和严重受损患者的6年死亡率分别为2.7%、5.2%和31.1%。在每个LVEF组中,RD患者的短期和长期预后均较差。在多变量Cox分析中,RD仍然是中度(HR 2.52,95%CI 1.54-3.78)和严重受损收缩功能患者6年死亡率的独立预测因素,但在左心室收缩功能正常的患者中不是(HR 0.59,95%CI 0.14-1.41)。
尽管无论LVEF如何,RD患者在STEMI后的6年死亡率较高,但入院时的RD仍然只是左心室收缩功能中度和严重受损患者6年死亡率的强有力独立预测因素。